Acorda Therapeutics Inc (ACOR)

0.42 ↓0.02 (-4.43%)
As of May 25, 2022, 9:48am EST.

ACOR Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $0.44 - $5.23
  • Market Capitalization: $6.56M
  • Short Percentage: 0%
  • Target Price: $10.00
  • Shares Outstanding: 13.29M
  • Next Earnings: Aug 4
View More Stats

Catalysts

DateCategoryCatalyst
2022-03-03
Earnings

ACOR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $2.18 Close: -0.46% Next Day: -1.83% Next Week: -14.22% View More
0 Comments Share
2022-08-04
Earnings

ACOR will release their earnings report for the previous quarter and provide guidance for the current and upcoming quarters.

Open: N/A Close: N/A Next Day: N/A Next Week: N/A View More
0 Comments Share
Help your fellow traders

Company Info

Stock Details

  • Current Price: $0.42
  • 52-Week Low: $0.44
  • 52-Week High: $5.23
  • Most Recent Quarter: 2022-03-31
  • Shares Float: 12.35M
  • Shares Outstanding: 13.29M
  • Market Capitalization: $6.56M
  • Next Earnings Date: 2022-08-04

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 0.00%

The short interest for Acorda Therapeutics Inc is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 73.23%
Insiders: 1.33%
Instutitions: 25.44%

Analyst Target Price

10.00

Acorda Therapeutics Inc is currently $9.56 below Wallstreet Analysts' price target.

Yesterday's Volume

775,681

Interest in Acorda Therapeutics Inc has been trending up. The average daily volume in the past 14 days is 301,927.

Discussions

Please log in or register to share your thoughts.

millimaker3/29/22 01:41pm

$ACOR Markets about as efficient as a retirement home

0 Like Report
troubledelights10/31/21 05:42am

$ACOR money comes and goes but your story stays with you the rest of your life. Apes for life ??

0 Like Report